PT-141 vs Kisspeptin
PT-141 (Bremelanotide) and Kisspeptin are both studied in reproductive and sexual function research, but their mechanisms and points of action within the reproductive axis differ substantially. PT-141 is a cyclic heptapeptide melanocortin receptor agonist that acts centrally through MC3R and MC4R to influence sexual arousal and behavior via dopaminergic pathways. Kisspeptin is the primary upstream neuropeptide regulator of the gonadotropin-releasing hormone (GnRH) pulse generator, controlling the downstream release of LH, FSH, and ultimately gonadal steroid production. Researchers designing reproductive biology studies typically select based on whether the target is central arousal signaling or the hypothalamic-pituitary-gonadal axis.
PT-141
Cyclic heptapeptide, melanocortin agonist
Kisspeptin
Neuropeptide (Kisspeptin-10 is 10 AA; Kisspeptin-54 is 54 AA)
At a Glance
Key research profiles for each compound.
PT-141
Melanocortin receptor agonist studied for reproductive and sexual behavior research
Class
Cyclic heptapeptide, melanocortin agonist
Mechanism
MC3R and MC4R agonism, central dopaminergic signaling
Half-Life
Estimated 2 to 4 hours in pharmacokinetic models
Research Area
Reproductive behavior, sexual function, CNS melanocortin system
- Investigated for MC3R and MC4R agonism in central reproductive signaling models
- Studied for its role in sexual behavior and arousal in rodent preclinical models
- Examined for dopaminergic system interactions in reward pathway research
- Documented effects on penile erection and female receptivity in animal models
Kisspeptin
GPR54 ligand studied for GnRH modulation and reproductive axis research
Class
Neuropeptide (Kisspeptin-10 is 10 AA; Kisspeptin-54 is 54 AA)
Mechanism
GPR54 agonism, GnRH neuron stimulation, LH/FSH release
Half-Life
Short for Kisspeptin-10, longer for Kisspeptin-54 in models
Research Area
Reproductive axis, fertility, puberty, neuroendocrinology
- Studied as the primary upstream regulator of the GnRH pulse generator
- Investigated for LH and FSH surge modulation in reproductive endocrinology
- Examined for role in puberty onset and gonadotropin axis regulation in animal models
- Documented effects on sexual motivation and olfactory cue processing in rodents
Side-by-Side Comparison
Key research parameters compared directly.
| Feature | PT-141 | Kisspeptin |
|---|---|---|
| Compound Class | Cyclic heptapeptide, melanocortin agonist | Neuropeptide, GPR54 ligand |
| Primary Mechanism | MC3R/MC4R agonism, dopaminergic signaling | GPR54 activation, GnRH pulse stimulation |
| Axis Target | Central melanocortin and reward pathways | Hypothalamic-pituitary-gonadal (HPG) axis |
| Downstream Effect | Sexual arousal and behavior in animal models | LH/FSH release, gonadal steroid production |
| Research Origin | Developed from alpha-MSH analog (Melanotan II) | Identified as 'metastin' in cancer suppression research, later linked to GnRH |
| Clinical Research | FDA-approved form (Vyleesi) for HSDD | Human clinical trials for reproductive disorders |
| CNS Relevance | High, acts centrally through MC receptors | High, hypothalamic GnRH neuron activation |
| Fertility Axis | Indirect, via behavioral and arousal mechanisms | Direct upstream regulator of gonadotropin release |
Research Deep-Dive
PT-141
PT-141 (Bremelanotide) is a cyclic analog of alpha-MSH (alpha-melanocyte-stimulating hormone) developed from the earlier compound Melanotan II. Its sexual behavior research profile is centered on agonism of the MC3 and MC4 melanocortin receptor subtypes, which are expressed in hypothalamic and limbic regions involved in sexual arousal and reward processing. In animal models, PT-141 administration has been associated with increased sexual receptivity in female rodents and facilitated erection in male models through central dopaminergic pathway activation. A nasal spray formulation (Vyleesi) received FDA approval in 2019 for hypoactive sexual desire disorder (HSDD) in premenopausal women, making PT-141 one of the few peptides in this class with regulatory approval.
View PT-141 →Kisspeptin
Kisspeptin (also known as metastin, named after Hershey, Pennsylvania, where it was first identified) is the endogenous ligand for the G-protein coupled receptor GPR54. It was initially identified as a tumor metastasis suppressor before its critical role in reproductive neuroendocrinology was recognized. Kisspeptin neurons in the hypothalamic arcuate and anteroventral periventricular nuclei serve as the primary pulse generator for gonadotropin-releasing hormone (GnRH), making Kisspeptin the upstream master regulator of the entire hypothalamic-pituitary-gonadal (HPG) axis. Research has examined Kisspeptin in the contexts of puberty onset timing, fertility disorders, and the neuroendocrine control of the LH surge in ovulation. Human clinical studies have investigated Kisspeptin administration in conditions of hypothalamic amenorrhea and male hypogonadotropic hypogonadism.
View Kisspeptin →Research Context
PT-141 and Kisspeptin represent two distinct entry points into the reproductive and sexual function research space. PT-141 addresses the behavioral and central arousal dimension through melanocortin signaling. Kisspeptin addresses the neuroendocrine and hormonal dimension through GnRH axis regulation. Researchers designing comprehensive reproductive biology protocols sometimes include both to capture the behavioral and endocrine aspects of sexual function simultaneously.
Frequently Asked Questions
Related Comparisons
Research Use Cases
Source Both Compounds
PT-141 and Kisspeptin are both available from Spartan Peptides at ≥98% HPLC-verified purity. Domestic US supply, same-day dispatch before 2 PM. All products for in-vitro research use only.
All compounds are strictly for in-vitro research use only and not intended for human consumption.